Search Results - "Sebio, Ana"

Exploring Dystrophin Expression and Mutations in the DMD and Dystrophin-Glycoprotein Complex Genes as Prognostic Factors in Leiomyosarcomas.

Authors: Salazar, Juliana Cerdà, Paula Artigas, Alícia et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 12, p5290. 13p.

VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.

Authors: Salazar, Juliana Arranz, María J. Martin-Broto, Javier et al.

Source: Pharmaceuticals (14248247). Dec2025, Vol. 18 Issue 12, p1855. 11p.

Surgical Management and Therapeutic Strategy of Uterine Sarcoma According to Histological Subtype and Staging: Updated Review and Recommendations.

Authors: Muñoz-Casares, Francisco Cristóbal Gómez-Barbadillo, José Álvarez-Álvarez, Rosa et al.

Source: Cancers. Jun2026, Vol. 18 Issue 12, p1870. 28p.

Role of Spatially Fractionated Radiotherapy (LATTICE) Treatment in Inoperable Bulky Soft-Tissue Sarcomas.

Authors: Majercakova, Katarina Aguilar, Natalia Tejedor Isern Verdum, Josep et al.

Source: Cancers. Feb2025, Vol. 17 Issue 4, p624. 11p.

Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines.

Authors: Vaz-Salgado, Maria Angeles Valverde-Morales, Claudia Alvarez, Rosa et al.

Source: Cancers. Oct2025, Vol. 17 Issue 19, p3158. 29p.

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol.

Authors: Salazar, Juliana Arranz, María J. Martin-Broto, Javier et al.

Source: Pharmaceutics. Dec2024, Vol. 16 Issue 12, p1585. 12p.

CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.

Authors: Virgili, Anna C. Salazar, Juliana Gallardo, Alberto et al.

Source: Diagnostics (2075-4418). Jun2024, Vol. 14 Issue 11, p1195. 11p.

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.

Authors: Serrano, César Vivancos, Ana López-Pousa, Antonio et al.

Source: BMC Cancer. 2/5/2020, Vol. 20 Issue 1, p1-12. 12p. 1 Diagram, 2 Charts, 3 Graphs.

New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting.

Authors: Roulleaux-Dugage, Matthieu Italiano, Antoine

Source: Journal of Hematology & Oncology. 8/8/2023, Vol. 16 Issue 1, p1-5. 5p.

Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations.

Authors: Muñoz-Casares, Francisco Cristóbal Martín-Broto, Javier Cascales-Campos, Pedro et al.

Source: Cancers. Aug2024, Vol. 16 Issue 15, p2646. 28p.

Volume 24 Author Index.

Source: The oncologist Dec2019; Vol. 24 (12).

Journal Info: Publisher: Oxford University Press / USA ISSN: 1083-7159

Quality of Life and Patient‐Reported Outcomes in Patients With Osteosarcoma: A Systematic Review.

Authors: Sebio, Ana Berger, Claire Tabone, Marie-Dominique et al.

Source: European journal of cancer care 4/2/2025; Vol. 2025.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0961-5423

A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report.

Authors: Moura, David S. Díaz-Martín, Juan Bagué, Silvia et al.

Source: International Journal of Molecular Sciences. Jul2021, Vol. 22 Issue 14, p7514-7514. 1p.

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases.

Authors: Stremitzer, Stefan Zhang, Wu Yang, Dongyun et al.

Source: Cancer (0008543X). Jun2015, Vol. 121 Issue 11, p1898-1905. 8p.

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients.

Authors: Riera, Pau Rodríguez-Santiago, Benjamín Lasa, Adriana et al.

Source: Cancers. Aug2020, Vol. 12 Issue 8, p2245-2245. 1p.